Objectives: To determine the prevalence and risk factors for, and the association with in-hospital mortality of, AMI after AIS, and to study the effect of intravenous recombinant tissue plasminogen activator (r-tPA) in this setting. We hypothesized that AMI would be associated with lower survival rate at hospital discharge but that intravenous r-tPA would be associated with lower risk of AMI.
Recommended CitationSeifi, MD, Ali; Rincon, MD, MSc, Fred; Moussouttas, MD, Michael; Maltenfort, PhD, Mitchell; Vibbert, MD, Matthew; Bell, MD, Rodney; Pineda, MD, Maria Carissa; Tzeng, MD, Diana; Urtecho, MD, Jacqueline; Koka, MD, Anish; and McBride, MD, William, "The Prevalence and Risk Factors of Acute Myocardial Infarction (AMI) After Acute Ischemic Stroke (AIS) in the United States" (2011). Department of Neurology Faculty Papers. Paper 41.